Back

Prediction of pharmacological reverse remodeling in non-ischemic dilated cardiomyopathy with wide QRS-complex.

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Kenji Maemura

Kitasato University School of Medicine, Kanagawa (Japan)

43 More presentations in this session

Presentation thumbnail
Doctor K. Kodziszewska (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor A. Pouleur (Brussels, BE)
Abstract Slides
Presentation thumbnail
Professor H. Badran (Shibin El Kom, EG)
Presentation thumbnail
Doctor A. Vorobev (Ulyanovsk, RU)
Abstract
Presentation thumbnail
Doctor A. Duszanska (Kedzierzyn-Kozle, PL)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
High dosages of betablockers are related to left ventricular reverse remodelling in patients with recent-onset non-ischaemic dilated cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Impact of changes in QRS fragmentation with cardiac resynchronisation therapy: differences between ischaemic and non-ischaemic aetiologies.
30 August 2025
thumbnail
Congress Presentation
A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction
21 May 2023
thumbnail
Congress Session
When the rhythm is of the essence
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources